ATE253590T1 - Peptide, bronchodilator und den blutstrom verbesserndes mittel - Google Patents

Peptide, bronchodilator und den blutstrom verbesserndes mittel

Info

Publication number
ATE253590T1
ATE253590T1 AT96916331T AT96916331T ATE253590T1 AT E253590 T1 ATE253590 T1 AT E253590T1 AT 96916331 T AT96916331 T AT 96916331T AT 96916331 T AT96916331 T AT 96916331T AT E253590 T1 ATE253590 T1 AT E253590T1
Authority
AT
Austria
Prior art keywords
asn
leu
ala
ser
val
Prior art date
Application number
AT96916331T
Other languages
English (en)
Inventor
Kazuhisa Kashimoto
Yumiko Nagano
Original Assignee
Itoham Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7143581A external-priority patent/JPH08333276A/ja
Priority claimed from JP7255370A external-priority patent/JPH09100237A/ja
Application filed by Itoham Foods Inc filed Critical Itoham Foods Inc
Application granted granted Critical
Publication of ATE253590T1 publication Critical patent/ATE253590T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96916331T 1995-06-09 1996-06-06 Peptide, bronchodilator und den blutstrom verbesserndes mittel ATE253590T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7143581A JPH08333276A (ja) 1995-06-09 1995-06-09 ペプチド及び気管支拡張剤
JP7255370A JPH09100237A (ja) 1995-10-02 1995-10-02 血流改善剤
PCT/JP1996/001543 WO1996041814A1 (fr) 1995-06-09 1996-06-06 Peptide, bronchodilatateur et agent facilitant l'ecoulement sanguin

Publications (1)

Publication Number Publication Date
ATE253590T1 true ATE253590T1 (de) 2003-11-15

Family

ID=26475273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916331T ATE253590T1 (de) 1995-06-09 1996-06-06 Peptide, bronchodilator und den blutstrom verbesserndes mittel

Country Status (8)

Country Link
US (1) US5856303A (de)
EP (1) EP0796867B1 (de)
CN (1) CN1124283C (de)
AT (1) ATE253590T1 (de)
AU (1) AU682638B2 (de)
CA (1) CA2196308C (de)
DE (1) DE69630583T2 (de)
WO (1) WO1996041814A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449789T1 (de) * 1998-07-20 2009-12-15 Ipsen Pharma Pacap-peptidanaloga
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
WO2001023420A2 (en) * 1999-09-28 2001-04-05 Bayer Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
WO2001060862A1 (en) * 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6608174B1 (en) 2000-02-18 2003-08-19 Dabur Research Foundation Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
WO2003039577A1 (fr) * 2001-11-06 2003-05-15 Senju Pharmaceutical Co., Ltd. Remedes contre l'oeil sec et des maladies associees a l'oeil sec
CN100381462C (zh) * 2002-11-27 2008-04-16 伊藤火腿株式会社 肽及含有所述肽的药物组合物
JP5088471B2 (ja) * 2007-07-25 2012-12-05 Ｊｓｒ株式会社 標的物質の検出方法およびラテックス凝集反応用試薬
KR102635553B1 (ko) * 2018-12-28 2024-02-13 주식회사 리비옴 외래 단백질을 발현하는 미생물, 및 그의 용도
KR102527953B1 (ko) * 2021-03-29 2023-05-03 주식회사 리비옴 외래 단백질을 발현하는 미생물, 및 그의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734400A (en) * 1984-10-09 1988-03-29 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
SE8705139D0 (sv) * 1987-12-23 1987-12-23 Trion Forskning & Utveckling Forfarande for framstellning av ett stort antal peptidanaloger och nya peptidanaloger
DE69101187T2 (de) * 1990-06-26 1994-09-29 Sanwa Kagaku Kenkyusho Co VIP-Analogen und ihre Verwendung.
JPH0692991A (ja) * 1991-02-28 1994-04-05 Daicel Chem Ind Ltd 新規活性ペプチド
JP3137349B2 (ja) * 1991-03-27 2001-02-19 生化学工業株式会社 ペプチド誘導体
JPH06220090A (ja) * 1993-01-22 1994-08-09 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド

Also Published As

Publication number Publication date
CN1161043A (zh) 1997-10-01
DE69630583T2 (de) 2004-09-30
EP0796867B1 (de) 2003-11-05
DE69630583D1 (de) 2003-12-11
CN1124283C (zh) 2003-10-15
EP0796867A1 (de) 1997-09-24
CA2196308C (en) 2000-10-17
AU5911296A (en) 1997-01-09
CA2196308A1 (en) 1996-12-27
WO1996041814A1 (fr) 1996-12-27
EP0796867A4 (de) 1999-10-20
AU682638B2 (en) 1997-10-09
US5856303A (en) 1999-01-05

Similar Documents

Publication Publication Date Title
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
ES2103857T3 (es) Peptidos ciclicos y su uso.
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
ES2117088T3 (es) Derivados de aminocetonas.
NO891870L (no) Fremgangsmaate for fremstilling av peptider.
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ATE253590T1 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
NO871574L (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
ES2098510T3 (es) Antagonista de galanina.
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE245168T1 (de) Peptide, die anti-zellanhaftungsaktivität aufweisen
ATE390440T1 (de) Neuroaktive peptide
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
DE69434151D1 (de) Therapeutische inhaltsstoffe
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
ATE388965T1 (de) Menschliche antithrombin-varianten
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
CA2216704A1 (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties